Материал: nm1391

Внимание! Если размещение файла нарушает Ваши авторские права, то обязательно сообщите нам

 

T E C H N I C A L R E P O R T S

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

a 20

 

 

 

 

b 6,000

 

 

 

c

 

–6,000

 

 

 

 

d 2.0

 

 

 

 

 

 

 

 

 

 

 

 

*

 

 

 

 

 

 

 

 

*†‡

 

 

 

 

 

 

†‡

AWT diastole (mm)

1.6

 

 

 

 

 

 

 

 

 

 

15

 

 

*

 

Max dP/dt (mmHg/s)

 

 

 

 

*

Min dP/dt (mmHg/s)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LVEDP (mmHg)

 

 

 

4,000

 

*

 

–4,000

 

 

*

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

*

 

1.2

 

 

*†‡§

 

 

 

Sham

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Untreated

 

10

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

DFB

 

 

 

 

 

 

*†‡

 

 

 

 

 

 

 

 

 

 

 

 

0.8

*

 

*

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

MSC

 

 

 

 

 

2,000

 

 

 

 

–2,000

 

 

 

 

 

 

 

 

 

 

5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.4

* *

 

*

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0

 

 

 

 

 

 

0

 

 

 

 

 

 

0

 

 

 

 

 

0

 

 

 

 

 

 

 

 

http://www.nature.com/naturemedicine

 

 

Sham

ntreated

DFB

MSC

 

 

 

Sham

ntreated

DFB

MSC

 

 

 

Sham

ntreated

DFB

MSC

 

Baseline

After treatment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U

 

 

 

 

 

U

 

 

 

 

 

U

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

e

11

 

 

 

*§

f

50

 

 

 

g

 

 

2,000

 

 

 

*§

h

Coronary ligation

Transplantation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

100

 

 

 

 

 

 

 

 

 

10

*

 

*§

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

40

 

 

 

 

(pg/ml)

1,500

 

 

 

 

 

80

 

 

 

 

 

 

 

 

 

 

* *

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

MSC group

 

9

 

*†‡

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(mm)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(n = 20)

 

 

30

 

 

 

 

level

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

60

 

 

 

 

 

 

 

 

8

 

 

 

 

 

 

 

 

 

 

*†‡

1,000

*

 

 

*§

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LVDD

 

 

 

 

 

20

 

*

 

Plasma ANP

 

 

 

40

 

 

 

 

 

 

 

 

7

 

 

 

 

 

 

 

*

 

 

 

 

 

 

 

 

 

 

 

Untreated group

 

 

 

 

 

 

 

 

 

 

500

* *

 

 

*†‡

 

 

 

 

 

 

 

6

 

 

 

§

 

10

* *

 

*

 

 

 

20

 

 

 

 

 

 

(n = 20)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5

 

 

 

 

 

0

 

 

 

 

 

 

0

 

 

 

 

 

0

 

 

 

 

 

 

 

 

 

Baseline

After treatment

 

Baseline

After treatment

 

 

Baseline

After treatment

 

0

1

2

3

4

5

6

7

8

 

 

 

 

 

 

 

 

 

Figure 5 Cardiac structure and function afterPercentageFS

transplantation of monolayered MSCs. (a–c) Hemodynamic parametersSurvivalrate(percent)

 

 

Time (weeks)

 

 

 

obtained by catheterization. LVEDP, left

Group

ventricle end-diastolic pressure. (d–f) Echocardiographic findings. AWT, anterior wall thickness; LVDD, left ventricle end-diastolic dimension; FS, fractional

shortening. (g) Plasma atrial natriuretic peptide (ANP) level. Baseline represents measurements 4 weeks after coronary ligation; ’after treatment’ represents

measurements taken 4 weeks after transplantation (8 weeks after coronary ligation). Data are mean ± s.e.m. *P o 0.05 versus sham group; wP o 0.05

versus untreated group; zP o 0.05 versus DFB group; yP o 0.05 versus baseline. (h) Survival of rats with chronic heart failure with or without monolayered

Publishing

MSC transplantation. The Kaplan-Meier survival curve demonstrates an 8-week survival rate of 65% for the MSC group versus 45% for the untreated group.

Survival rate after transplantation was significantly higher in the MSC group than in the untreated group (100% versus 71% 4-week survival rate after

transplantation, log-rank test, P o 0.05).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nature

conditions at 37 1C and becomes reversibly hydrophilic below 32 1C. Therefore,

 

COMPETING INTERESTS STATEMENT

 

 

 

 

 

 

 

cultured cells that adhere to the dish surface spontaneously detach from the

 

The authors declare competing financial interests (see the Nature Medicine website

grafted surface without enzymatic digestion.

 

 

 

 

 

 

 

for details).

 

 

 

 

 

 

 

 

 

 

 

 

2006

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Preparation of monolayered cell grafts. We suspended MSCs at the third or

 

Published online at http://www.nature.com/naturemedicine/

 

 

 

 

©

fourth

passage from adipose

tissue or DFBs at the second passage by

 

Reprints and permissions information is available online at http://npg.nature.com/

 

trypsinization, and plated the cell suspension containing 3 ml of complete

 

reprintsandpermissions/

 

 

 

 

 

 

 

 

 

 

 

medium onto a 60-mm temperature-responsive dish at 5 105 cells per dish

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(MSCs) or 8 105 cells per dish (DFBs) and cultured cells at 37 1C. After 3 d of

 

1.

Liu, J. et al. Autologous stem cell transplantation for myocardial repair. Am. J. Physiol.

 

culture, confluently cultured MSCs or DFBs on the temperature-responsive

 

 

Heart Circ. Physiol. 287, H501–H511 (2004).

 

 

 

 

 

 

 

dishes were incubated at 20 1C. By 40 min, both MSCs and DFBs detached

 

2.

Reinlib, L. & Field, L. Cell transplantation as future therapy for cardiovascular disease?:

 

spontaneously and floated up into the medium as monolayered cell grafts.

 

 

A workshop of the National Heart, Lung, and Blood Institute. Circulation 101, E182–

 

Immediately after detachment, we gently aspirated the monolayered cell grafts

 

 

E187 (2000).

 

 

 

 

 

 

 

 

 

 

 

 

3. Schuster, M.D. et al. Myocardial neovascularization by bone marrow angioblasts results

 

using a 1,000 ml pipette tip and transferred them onto an elastic plastic sheet.

 

 

 

 

in cardiomyocyte regeneration. Am. J. Physiol. Heart Circ. Physiol. 287, H525–H532

 

Statistical analysis. Numerical values are expressed as mean ± s.e.m. There are

 

 

(2004).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4.

Kocher, A.A. et al. Neovascularization of ischemic myocardium by human bone-

 

four groups of continuous variables in this study. Therefore, for multiple

 

 

marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling

 

comparisons of more than two groups, we performed one-way analysis of

 

 

and improves cardiac function. Nat. Med. 7, 430–436 (2001).

 

 

 

 

variance (ANOVA). If the ANOVA was significant, we used the Newman-Keul

 

5. Bel, A. et al. Transplantation of autologous fresh bone marrow into infarcted myocar-

 

 

 

dium: a word of caution. Circulation 108, II247–II252 (2003).

 

 

 

 

procedure as a post hoc test. For repeated measurement such as echocardio-

 

 

 

 

 

 

 

6.

Yamada, N. et al. Thermo-responsive polymeric surface: control of attachment and

 

graphic parameters, we performed two-way repeated ANOVA with the

 

 

detachment of cultured cells. Makromol. Chem. Rapid Commun. 11, 571–576

 

Newman-Keul test. Comparisons of parameters between two groups were made

 

 

(1990).

 

 

 

 

 

 

 

 

 

 

 

 

 

by unpaired Student t-test. A value of P o 0.05 was considered significant.

 

 

7. Okano, T., Yamada, H., Sakai, H. & Sakurai, Y. A novel recovery system for cultured

 

 

 

 

cells using plasma-treated polystyrene dishes grafted with poly (N-isopropylacryla-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Note: Supplementary information is available on the Nature Medicine website.

 

 

 

mide). J. Biomed. Mater. Res. 27, 1243–1251 (1993).

 

 

 

 

 

 

 

 

8.

Shimizu, T. et al. Fabrication of pulsatile cardiac tissue grafts using a novel 3-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

dimensional cell sheet manipulation technique and temperature-responsive cell

 

ACKNOWLEDGMENTS

 

 

 

 

 

 

 

 

 

 

 

culture surfaces. Circ. Res. 90, e40–e48 (2002).

 

 

 

 

 

 

 

We thank J.I. Hoffman for his statistical advice. We thank T. Iwase, T. Ito, S.

 

 

9.

Hirose, M., Kwon, O.H., Yamato, M., Kikuchi, A. & Okano, T. Creation of designed

 

Murakami, N. Sakata and Y. Isono for their technical support. We thank Y. Tsuboi

 

 

shape cell sheets that are noninvasively harvested and moved onto another surface.

 

 

 

Biomacromolecules 1, 377–381 (2000).

 

 

 

 

 

 

 

 

and H. Sonoda for their assistance with microscopic analysis of monolayered cell

 

 

 

 

 

 

 

 

 

 

 

 

 

10. Kushida, A. et al. Decrease in culture temperature releases monolayer endothelial cell

 

grafts. We also thank Y. Sawa for his suggestions on this study. This work was

 

 

 

 

 

 

sheets together with deposited fibronectin matrix from temperature-responsive culture

 

supported by research grants for Cardiovascular Disease (16C-6) and Human

 

 

 

 

 

 

 

surfaces. J. Biomed. Mater. Res. 45, 355–362 (1999).

 

 

 

 

 

 

Genome Tissue Engineering 005 and 009 from the Japanese Ministry of Health,

 

 

 

 

 

 

 

 

 

 

 

11. Herreros, J. et al. Autologous intramyocardial injection of cultured skeletal muscle-

 

Labor and Welfare, and the Program for Promotion of Fundamental Studies in

 

 

 

derived stem cells in patients with non-acute myocardial infarction. Eur. Heart J. 24,

 

Health Science of the Japanese National Institute of Biomedical Innovation.

 

 

 

2012–2020 (2003).

 

 

 

 

 

 

 

 

 

 

 

4 6 4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

VOLUME 12 [ NUMBER 4 [

APRIL 2006

NATURE MEDICINE

T E C H N I C A L R E P O R T S

© 2006 Nature Publishing Group http://www.nature.com/naturemedicine

12.Skobel, E. et al. Transplantation of fetal cardiomyocytes into infarcted rat hearts results in long-term functional improvement. Tissue Eng. 10, 849–864 (2004).

13.Hodgson, D.M. et al. Stable benefit of embryonic stem cell therapy in myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 287, H471–H479 (2004).

14.Makino, S. et al. Cardiomyocytes can be generated from marrow stromal cells in vitro.

J.Clin. Invest. 103, 697–705 (1999).

15.Pittenger, M.F. et al. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143–147 (1999).

16.Reyes, M. et al. Origin of endothelial progenitors in human postnatal bone marrow.

J.Clin. Invest. 109, 337–346 (2002).

17.Toma, C., Pittenger, M.F., Cahill, K.S., Byrne, B.J. & Kessler, P.D. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105, 93–98 (2002).

18.Wang, J.S. et al. Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. J. Thorac. Cardiovasc. Surg. 120, 999–1005 (2000).

19.Jiang, Y. et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418, 41–49 (2002).

20.Nagaya, N. et al. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 112, 1128–1135 (2005).

21.Rangappa, S., Fen, C., Lee, E.H., Bongso, A. & Wei, E.S. Transformation of adult mesenchymal stem cells isolated from the fatty tissue into cardiomyocytes. Ann. Thorac. Surg. 75, 775–779 (2003).

22.Zuk, P.A. et al. Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell 13, 4279–4295 (2002).

23.Gaustad, K.G., Boquest, A.C., Anderson, B.E., Gerdes, A.M. & Collas, P. Differentiation of human adipose tissue stem cells using extracts of rat cardiomyocytes. Biochem. Biophys. Res. Commun. 314, 420–427 (2004).

24.Planat-Benard, V. et al. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 109, 656–663 (2004).

25.Lee, R.H. et al. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell. Physiol. Biochem. 14, 311–324 (2004).

26.Li, J., Takaishi, K., Cook, W., McCorkle, S.K. & Unger, R.H. Insig-1 ‘‘brakes’’ lipogenesis in adipocytes and inhibits differentiation of preadipocytes. Proc. Natl. Acad. Sci. USA 100, 9476–9481 (2003).

27.Vande Berg, J.S., Rudolph, R. & Woodward, M. Comparative growth dynamics and morphology between cultured myofibroblasts from granulating wounds and dermal fibroblasts. Am. J. Pathol. 114, 187–200 (1984).

28.Nishida, K. et al. Corneal reconstruction with tissue-engineered cell sheets composed of autologous oral mucosal epithelium. N. Engl. J. Med. 351, 1187–1196 (2004).

29.Shimizu, T., Yamato, M., Kikuchi, A. & Okano, T. Cell sheet engineering for myocardial tissue reconstruction. Biomaterials 24, 2309–2316 (2003).

30.Nishikimi, T., Uchino, K. & Frohlich, E.D. Effects of a1-adrenergic blockade on intrarenal hemodynamics in heart failure rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 262, R198–R203 (1998).

NATURE MEDICINE VOLUME 12 [ NUMBER 4 [ APRIL 2006

4 6 5